Cognitive Dysfunction and Glucagon-like Peptide-1 Agonists
This study is completed. It focuses on depression and currently lists study information in Canada.
In Toronto
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed. It focuses on depression and currently lists study information in Canada.
In TorontoThis study has public registry information. It focuses on addiction and currently lists study information in Canada.
In TorontoThis study is completed. It focuses on depression and currently lists study information in France.
In ParisThis study is ongoing. It focuses on schizophrenia and currently lists study information in Spain.
In SpainThis study is completed. It focuses on schizophrenia and currently lists study information in the United States.
In BaltimoreThis study is completed. It focuses on schizophrenia and currently lists study information in Iran.
Multiple locations, including TehranThis study is completed. It focuses on bipolarity and currently lists study information in the United States.
In Glen OaksThis study is completed. It focuses on depression and currently lists study information in the United States.
In NashvilleThis study is completed. It focuses on schizophrenia and currently lists study information in Taiwan.
In TaipeiThis study is completed. It focuses on depression and currently lists study information in the United States.
In FarmingtonThis study is active but not recruiting. It focuses on depression and currently lists study information in China.
In GuangzhouThis study is active but not recruiting. It focuses on depression and currently lists study information in Denmark.
In AarhusHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.